Journal of Periodontology · 2017 · 36 citations · 38 references
DentistryOral BiologyPeriodontologyInflammationOral ImmunologyPeriodontal BiologyGingival BiologyGingival DiseaseGingival InflammationOral Antidiabetic AgentsPeriodontal DiseasePeriodontal InflammationAntidiabetic ActivityGingival Fibroblast BiologyGingival FibroblastsInflammatory Cytokine ProductionInflammatory Cytokine ProfilesInflammatory Response GenesOral Antidiabetic TherapyPorphyromonas Species
BACKGROUND: Chronic periodontitis, one of the most prevalent oral diseases, is associated with Porphyromonas gingivalis (Pg) lipopolysaccharide (LPS) infection and has profound effects on type 2 diabetes mellitus (t2DM). Metformin, a well-known antidiabetic agent, has been reported to exert anti-inflammatory effects on various cells. This study aims to investigate the role of metformin on LPS-influenced inflammatory response in human gingival fibroblasts (HGFs). METHODS: Dose-dependent additive effects of metformin on LPS-influenced HGFs were detected. Cell-counting assay was used to determine effects of metformin and LPS on viability of HGFs. Enzyme-linked immunosorbent assay and quantitative real-time polymerase chain reaction (qRT-PCR) were applied to detect levels of interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α in differently treated cells. Activating transcription factor-3 (ATF3) small interfering (si)RNA transfection was used to determine the mechanism of metformin action, and the transfection efficiency was observed by fluorescence microscope. Effects of ATF3 knockdown were determined by qRT-PCR and Western blot. RESULTS: Results showed that 5 μg/mL Pg LPS and 0.1, 0.5, and 1 mM metformin exhibited no toxicity to HGFs, and metformin inhibited LPS-influenced IL-1β, IL-6, and TNF-α production in a dose-dependent manner. Metformin and LPS could synergistically facilitate ATF3 expression, and ATF3 knockdown abolished inhibitory effects of metformin on LPS-influenced inflammatory cytokine production in HGFs. CONCLUSION: The present study confirms that metformin suppresses LPS-enhanced IL-6, IL-1β, and TNF-α production in HGFs via increasing ATF3 expression.
38
IL-6 is produced by osteoblasts and induces bone resorption.
Yoshiko Ishimi, Chisato Miyaura, Cheng Jin et al. · The Journal of Immunology · 1990 · 1.1K citations
Medicine, Endocrinology, Immunology +14
Mechanism by which metformin reduces glucose production in type 2 diabetes.
Ripudaman S. Hundal, Sylvie Dufour, Didier Laurent et al. · Diabetes · 2000 · 1.1K citations · Full text
Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4
Mark Gilchrist, Vésteinn Thórsson, Bin Li et al. · Nature · 2006 · 807 citations
Curt D. Wolfgang, D K Marsee, Andrew E. Allen et al. · PubMed · 1999 · 643 citations · Full text